|
Morrow, Gary R; Hickok, Jane T; Andrews, Paul L R et al. (2002) Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea? Psychophysiology 39:491-5
|
|
Hickok, J T; Roscoe, J A; Morrow, G R (2001) The role of patients' expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage 22:843-50
|
|
Roscoe, J A; Morrow, G R; Hickok, J T et al. (2000) Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage 20:113-21
|
|
Nair, M G; Hickok, J T; Roscoe, J A et al. (2000) Sources of information used by patients to learn about chemotherapy side effects. J Cancer Educ 15:19-22
|
|
Roscoe, J A; Hickok, J T; Morrow, G R (2000) Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med 22:121-6
|
|
Morrow, G R; Andrews, P L; Hickok, J T et al. (2000) Vagal changes following cancer chemotherapy: implications for the development of nausea. Psychophysiology 37:378-84
|
|
Morrow, G R; Hickok, J T; DuBeshter, B et al. (1999) Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea. J Auton Nerv Syst 78:57-63
|
|
Hickok, J T; Roscoe, J A; Morrow, G R et al. (1999) Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. Cancer 86:64-71
|
|
Morrow, G R; Roscoe, J A; Hickok, J T et al. (1998) Initial control of chemotherapy-induced nausea and vomiting in patient quality of life. Oncology (Williston Park) 12:32-7
|
|
Morrow, G R; Hickok, J T; Burish, T G et al. (1996) Frequency and clinical implications of delayed nausea and delayed emesis. Am J Clin Oncol 19:199-203
|
Showing the most recent 10 out of 14 publications
